Hepatitis


  • Stem Cells Could Drive Hepatitis Research Forward
    Hepatitis C, an infectious disease that can cause inflammation and organ failure, has different effects on different people. But no one is sure why some people are very susceptible to the infection, while others are resistant. Scientists believe that if they could study ...More
    1 week ago
    Posted in News
  • Researchers Identify a Cell-Permeable Peptide that Inhibits Hepatitis C
    Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis. This finding by Dr. Samuel French, an assistant ...More
    2 weeks ago
    Posted in News
  • Entry Point for Hepatitis C Infection is Identified
    A molecule embedded in the membrane of human liver cells that aids in cholesterol absorption also allows the entry of hepatitis C virus, the first step in hepatitis C infection, according to research at the University of Illinois at Chicago College of Medicine. The ...More
    3 weeks ago
    Posted in News
  • Many High-Risk Americans Don't Get Hepatitis B Vaccine
    A recently published study investigating hepatitis B vaccination rates in the United States found that more than half of adults at risk for hepatitis B virus remain unvaccinated. With many of these individuals making contact with the healthcare system, including HIV ...More
    3 weeks ago
    Posted in News
  • Combination of Oral Drugs Suppresses Common Type of Hepatitis C
    A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist. The study, which will be published Jan. 19, ...More
    3 weeks ago
    Posted in News
  • Researchers Identify Potential New Therapy Approach for Hepatitis C Infection
    Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus (HCV) in the liver that could lead to new therapies for those affected by this and other infectious diseases. More than 170 million people worldwide suffer ...More
    4 weeks ago
    Posted in News
  • Hepatitis C Virus Hijacks Liver MicroRNA
    Viral diseases are still one of the biggest challenges to medical science. Thanks to thousands of years of co-evolution with humans, their ability to harness the biology of their human hosts to survive and thrive makes them very difficult to target with medical treatment. ...More
    January 2, 2012
    Posted in News
  • Baby Boomers Most at Risk for Hepatitis C Virus
    Experts at Montefiore Medical Center urge the general public to be tested for hepatitis C virus, especially baby boomers, adults born between 1946-1964, who could be most at risk for this disease. Baby boomers are more likely to have been exposed to dangerous risk factors ...More
    December 2, 2011
    Posted in News, Infections & Pathogens
  • Experimental Drug Suppresses Rebound of HCV in Liver Transplant Patients
    A human monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) given to patients with chronic hepatitis C virus (HCV) infection undergoing liver transplantation significantly suppressed the virus for at least a week after ...More
    November 9, 2011
    Posted in News, Infections & Pathogens
  • Study Explores Economic Cost of Hepatitis C Patients with Advanced Liver Disease
    Healthcare costs for hepatitis C patients with end-stage liver disease are nearly 2.5 times higher than those in the early stages, according to a Henry Ford Hospital study. Although infection with the hepatitis C virus increases healthcare costs overall, the specific impact ...More
    November 9, 2011
    Posted in News, Infections & Pathogens
« Previous12345678910113839Next »